72189 080 20
Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72189-080
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72189-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
72189 080 30
This is a medication description. The medication is Cyclobenzaprine hydrochloride, which is the generic version of Flexeril. Each film-coated tablet contains 10mg of Cyclobenzaprine hydrochloride USP. The tablet is distributed by TruPharma LLC and the lot number is mentioned along with the "Discard After" date. The packaging and distribution details are also mentioned. The second half of the text appears to be unrelated to this medication description, and seems to contain some miscellaneous information.*
72189 080 60
This is a medication with the NDC code 7218908060 and generic name Cyclobenzaprine Hydrochloride. It is a muscle relaxant commonly used for the treatment of muscle spasms or pain. Each tablet of the medication contains 10mg of Cyclobenzaprine, and it is known as a generic alternative to the brand name drug Flexeril.*
72189 080 72
This is a description of Cyclobenzaprine Hydrochloride, a medication used to treat muscle spasms. The medication comes in the form of a tablet, containing 120 tabs, and has an expiration date of 4/30/21. The medication's NDC number is 7218908072, and its lot number is 4152-01072. The medication is manufactured by Genencor and is also known as Flexeril.*
080 (72189 080 90)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
